BioSpace News Archive

Genetown

ImmunoGen to Present Full Results from SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer at the Society of Gynecologic Oncology Annual Meeting

ImmunoGen, Inc. today announced that multiple abstracts were selected for oral and poster presentations at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer to be held on March 18-21, 2022 in Phoenix, Arizona.

March 10, 2022
·
5 min read
NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments

NeonMind Biosciences Inc. today provided a summary of business highlights on the Company’s activities and progress across its Pharmaceutical and Medical Services Divisions.

March 10, 2022
·
6 min read
Business

Cingulate Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Clinical and Business Update

Cingulate Inc. today announced its financial results for the three and 12 months ended December 31, 2021, and provided a clinical and business update.

March 10, 2022
·
10 min read
Business

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

TherapeuticsMD, Inc. today reported financial results for the fourth quarter ended December 31, 2021.

March 10, 2022
·
12 min read
BioMidwest

Xeris Announces $150M Senior Secured Term Loan Facility With Hayfin Capital

Xeris Biopharma Holdings, Inc. today announced it has entered into a senior secured term loan agreement (“debt facility”) with funds managed by Hayfin Capital Management LLP (“Hayfin”) to provide Xeris with up to a total of $150 million of capital.

March 10, 2022
·
7 min read
Genetown

Oncorus to Present at the Oppenheimer 32nd Annual Healthcare Conference

Oncorus, Inc. announced that President and Chief Executive Officer, Theodore Ashburn, M.D., Ph.D., will present at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 4:40 p.m. ET.

March 10, 2022
·
1 min read
Business

Galera Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Updates

Galera Therapeutics, Inc. announced financial results for the fourth quarter and year ended December 31, 2021 and provided recent corporate updates.

March 10, 2022
·
11 min read
Business

Akouos Appoints Aaron Tward, M.D., Ph.D., as Chief Scientific Officer

Akouos, Inc., a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, announced the appointment of Aaron Tward, M.D., Ph.D., as chief scientific officer.

March 10, 2022
·
3 min read
Pharm Country

Baudax Bio to Present at the Oppenheimer 32nd Annual Healthcare Conference

Baudax Bio, Inc. announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 2:40 p.m. Eastern Time.

March 10, 2022
·
1 min read
Business

ObsEva Announces Year End 2021 Financial Results and Provides Corporate Update

ObsEva SA, a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, reported financial results for the full year ended December 31, 2021 and provided a business update.

March 10, 2022
·
13 min read